Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Teladoc Health, Inc. (TDOC) had Revenue of $642.27M for the most recently reported fiscal quarter, ending 2025-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-12-31

Income Statement Financials
Revenue	$642.27M
Net Income	$-25.14M
Cost of Goods Sold	$197.05M
Gross Profit	$445.22M
Operating Expenses	$678.27M
Operating Income	$-36.00M
Non-Operating Income/Expense	$2.38M
Pre-Tax Income	$-33.62M
Normalized Pre-Tax Income	$-33.62M
Income after Taxes	$-25.14M
Income from Continuous Operations	$-25.14M
Consolidated Net Income/Loss	$-25.14M
Normalized Income after Taxes	$-25.14M
EBIT	$-36.00M
EBITDA	$63.22M
Weighted-Average Shares Outstanding (Basic)	176.22M
Weighted-Average Shares Outstanding (Diluted)	176.22M
Earnings per Share (EPS) (Basic)	$-0.14
Earnings per Share (EPS) (Diluted)	$-0.14
Balance Sheet Financials
Current Assets	$1.12B
Property, Plant, and Equipment	$26.97M
Long-Term Assets	$1.74B
Total Assets	$2.86B
Current Liabilities	$404.74M
Long-Term Debt	$994.92M
Long-Term Liabilities	$1.07B
Total Liabilities	$1.47B
Common Equity	$1.39B
Tangible Shareholders Equity	$-194.57M
Shareholders Equity	$1.39B
Common Shares Outstanding	178.31M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$294.36M
Cash Flow from Investing Activities	$-266.00M
Cash Flow from Financial Activities	$-551.65M
Beginning Cash	$1.30B
End Cash	$781.08M
Increase/Decrease in Cash	$-517.24M
Stock-Based Compensation	$80.41M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.77
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.42
Debt to Equity Ratio	0.72
Gross Margin	69.32%
Operating Margin	-5.60%
EBIT Margin	-5.60%
EBITDA Margin	--
Pre-Tax Profit Margin	-5.23%
Profit Margin	-3.91%
Free Cash Flow	$166.90M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.22
Inventory Turnover	5.16
Receiveable Turnover	3.33
Days Sales in Receivables	27.02
Return on Equity	-1.81%
Return on Tangible Equity	12.92%
Return on Assets	-0.88%
Return on Investments	-1.06%
Book Value Per Share	$7.77
Free Cash Flow per Share	$0.95
Operating Cash Flow per Share	$1.67

Data from Zacks Investment Research, Inc.